High‐dose superselective intra‐arterial cisplatin and concomitant radiation (radplat) for advanced head and neck cancer

Abstract

Supradose superselective intra-arterial cisplatin and concomitant radiation is an effective organ-preserving therapy in an unfavorable group of patients. Our series confirms encouraging results reported previously. This regimen is justified in unresectable patients despite the substantial toxicity.